CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation
Journal of the Society for Clinical Data Management · 2023
DOI: 10.47912/jscdm.169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Society for Clinical Data Management, 2023. Verfasst von Geoffrey Mann und 12 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The use of standardized data formats has increasingly facilitated both the submission of clinical trial data by pharmaceutical companies and its review by regulatory agencies. The Clinical Data Interchange Standards Consortium (CDISC) format has become the de facto worldwide standard for clinical trial data submissions and review. CDISC data are captured and organized in defined datasets, or domains, with predefined variable names and attributes. As a result, researchers and reviewers have a consistent, repeatable, and rapid way to load, review, and analyze data. The benefits provided by this standardization have culminated in the development of software that intuitively utilizes CDISC structures to quickly import and analyze the data as well as summarize the results for scientists and clinicians in a collection of readable and easy-to-understand reports. In this paper, we will show how CDISC datasets with their required domains and respective variables can be utilized by JMP® Clinical to create clinical trial analysis reports easily and quickly with interactive graphs and tables for use in FDA New Drug Applications and Clinical Reviews. These reports are also ready for inclusion in regulatory submissions such as regulatory documents and clinical study reports to improve reviewability, interpretability, and efficiency of regulatory submission and review.
Zitieren
APA
Mann, G., Pedersen, T. J., Lyzinski, R., Scott, A., Foglia, A. J., Cromer, J., Dong, M., Varga, N., Gardner, S., Kirchberg, C. J., Wingerd, B. A., Wolfinger, R. D., & Bao, W. (2023). CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation. Journal of the Society for Clinical Data Management. https://doi.org/10.47912/jscdm.169
Vancouver
Mann G, Pedersen TJ, Lyzinski R, Scott A, Foglia AJ, Cromer J, et al. CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation. Journal of the Society for Clinical Data Management. 2023. doi:10.47912/jscdm.169
BibTeX
@article{Mann2023,
author = {Mann, Geoffrey and Pedersen, Thomas J and Lyzinski, Rebecca and Scott, Anisa and Foglia, Andrew J and Cromer, John and Dong, Meichen and Varga, Nora and Gardner, Sam and Kirchberg, Christopher J and Wingerd, Byron A and Wolfinger, Russell D and Bao, Wenjun},
title = {CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation},
journal = {Journal of the Society for Clinical Data Management},
year = {2023},
doi = {10.47912/jscdm.169}
}
EUVIMED